Free Stock Screener
Load Save Create a watchlist HelpProfit margin
Debt to assets
Cash flow
Balance sheet
(in millions CNY) | 30 Sep 2023 | 31 Mar 2023 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | ¥94.64 | ¥163.7 | |||
Short term investments | ¥17.14 | ||||
Net receivables | ¥663.24 | ¥628.51 | |||
Inventory | ¥0.017 | ¥0.03 | |||
Other current assets | ¥3.06 | ¥3.06 | |||
Total current assets | ¥844.99 | ¥858.11 | |||
Long term investments | ¥0.3 | ¥0.3 | |||
Property, plant & equipment | ¥155.96 | ¥148.43 | |||
Goodwill | ¥281.58 | ¥281.58 | |||
Intangible assets | ¥174.55 | ¥180.12 | |||
Other assets | ¥18.77 | ¥16 | |||
Deferred long term asset charges | |||||
Total assets | ¥1,483.73 | ¥1,492.82 | |||
Current liabilities | |||||
Accounts payable | ¥25.35 | ¥11.52 | |||
Short long term debt | ¥82.18 | ¥91.6 | |||
Other current liabilities | ¥106.48 | ¥70.82 | |||
Total current liabilities | ¥214 | ¥239.42 | |||
Long term debt | ¥214.26 | ¥202.47 | |||
Other liabilities | -¥116.56 | -¥142.16 | |||
Deferred long term liabilities | |||||
Minority interest | ¥9.84 | ¥11.69 | |||
Total liabilities | ¥447.78 | ¥466.97 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | ¥40.44 | ¥40.44 | |||
Retained earnings | -¥143.87 | -¥155.4 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | ¥14.3 | ¥15.74 | |||
Total stockholder equity | ¥1,035.95 | ¥1,025.86 | |||
Net tangible assets |
(in millions CNY) | 2023 | 2022 | ||
---|---|---|---|---|
Current assets | ||||
Cash | ¥163.7 | ¥86.05 | ||
Short term investments | ¥17.14 | ¥32.93 | ||
Net receivables | ¥628.51 | ¥518.88 | ||
Inventory | ¥0.03 | ¥1.38 | ||
Other current assets | ¥3.06 | |||
Total current assets | ¥858.11 | ¥666.19 | ||
Long term investments | ¥0.3 | ¥21.55 | ||
Property, plant & equipment | ¥148.43 | ¥112.87 | ||
Goodwill | ¥281.58 | ¥581.82 | ||
Intangible assets | ¥180.12 | ¥184.08 | ||
Other assets | ¥16 | ¥0.672 | ||
Deferred long term asset charges | ||||
Total assets | ¥1,492.82 | ¥1,574.1 | ||
Current liabilities | ||||
Accounts payable | ¥11.52 | ¥11.35 | ||
Short long term debt | ¥91.6 | ¥161.74 | ||
Other current liabilities | ¥70.82 | ¥94.66 | ||
Total current liabilities | ¥239.42 | ¥314.17 | ||
Long term debt | ¥202.47 | ¥17.99 | ||
Other liabilities | -¥142.14 | -¥79.93 | ||
Deferred long term liabilities | ||||
Minority interest | ¥11.69 | ¥20.15 | ||
Total liabilities | ¥466.97 | ¥482.85 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | ¥40.44 | ¥35.4 | ||
Retained earnings | -¥155.4 | ¥74.74 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | ¥15.74 | ¥36.24 | ||
Total stockholder equity | ¥1,025.86 | ¥1,091.25 | ||
Net tangible assets |
Income statement
(in millions CNY) | 30 Sep 2023 | 31 Mar 2023 | |
---|---|---|---|
Revenue | |||
Total revenue | ¥301.7 | ¥162.8 | |
Cost of revenue | ¥274.51 | ¥128.98 | |
Gross profit | ¥27.18 | ¥33.82 | |
Operating activities | |||
Research & development | ¥7.98 | ¥11.28 | |
Selling, general & administrative | ¥22.38 | ¥36.06 | |
Non-recurring | |||
Other operating expenses | ¥4.98 | ¥6.65 | |
Total operating expenses | ¥304.87 | ¥176.32 | |
Operating income | -¥3.18 | -¥13.52 | |
Income from continuing operations | |||
Net other income | ¥4.98 | ¥6.65 | |
EBIT | |||
Interest expense | -¥4.98 | -¥6.65 | |
Income before tax | -¥1.71 | -¥261.57 | |
Income tax expense | ¥0.745 | -¥0.713 | |
Minority interest | ¥9.84 | ¥11.69 | |
Net income from continuing ops | |||
Non-recurring events | |||
Discontinued operations | |||
Extraordinary items | |||
Effect of accounting change | |||
Other items | -¥1.07 | ¥232.63 | |
Net income | |||
Net income | ¥0.038 | -¥258 | |
Income (for common shares) | ¥0.038 | -¥258 |
(in millions CNY) | 2023 | 2022 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | ¥888.62 | ¥865.67 | ||
Cost of revenue | ¥767.38 | ¥678.6 | ||
Gross profit | ¥121.24 | ¥187.07 | ||
Operating activities | ||||
Research & development | ¥36.39 | ¥28.11 | ||
Selling, general & administrative | ¥93.62 | ¥103.45 | ||
Non-recurring | ||||
Other operating expenses | ¥25.47 | ¥17.07 | ||
Total operating expenses | ¥897.4 | ¥810.16 | ||
Operating income | -¥8.77 | ¥55.51 | ||
Income from continuing operations | ||||
Net other income | ¥25.47 | ¥17.07 | ||
EBIT | ||||
Interest expense | -¥25.47 | -¥17.07 | ||
Income before tax | -¥236.96 | ¥84.02 | ||
Income tax expense | -¥0.942 | ¥12.89 | ||
Minority interest | ¥11.69 | ¥20.15 | ||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ¥5.82 | |||
Effect of accounting change | ||||
Other items | ¥228.06 | -¥48.63 | ||
Net income | ||||
Net income | -¥230.14 | ¥80.35 | ||
Income (for common shares) | -¥230.14 | ¥80.34 |
Cash flows
(in millions CNY) | 30 Sep 2023 | |
---|---|---|
Net income | ¥11.52 | |
Operating activities | ||
Depreciation | ||
Net income adjustments | ||
Change in accounts receivable | ||
Changes in liabilities | ||
Changes in inventory | ||
Changes in other operating activities | ||
Total cash flows from operations | ¥22.63 | |
Investing activities | ||
Capital expenditures | -¥20.29 | |
Investments | ||
Other cash flows from investing | -¥35.03 | |
Total cash flows from investing | -¥55.32 | |
Financing activities | ||
Dividends paid | ||
Sale and purchase of stock | ||
Net borrowings | -¥34.28 | |
Other cash flows from financing | -¥2.46 | |
Total cash flows from financing | -¥36.74 | |
Effect of exchange rate | ||
Change in cash and equivalents | -¥69.06 |
(in millions CNY) | 2023 | 2022 | ||
---|---|---|---|---|
Net income | -¥230.14 | ¥80.35 | ||
Operating activities | ||||
Depreciation | ¥52.95 | ¥58.86 | ||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -¥46.02 | -¥33.27 | ||
Investing activities | ||||
Capital expenditures | -¥39.36 | -¥60.89 | ||
Investments | ||||
Other cash flows from investing | -¥12.85 | -¥22.28 | ||
Total cash flows from investing | -¥52.21 | -¥83.17 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ¥185.25 | |||
Net borrowings | -¥6.49 | ¥11.15 | ||
Other cash flows from financing | -¥7.42 | -¥1.53 | ||
Total cash flows from financing | ¥171.34 | ¥9.63 | ||
Effect of exchange rate | ¥0.525 | ¥1.83 | ||
Change in cash and equivalents | ¥77.65 | -¥112.16 |
ZYT
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions GBP) | 31 Mar 2024 | 31 Mar 2023 | |
---|---|---|---|
Current assets | |||
Cash | £1 | £0.85 | |
Short term investments | £2.66 | £4.54 | |
Net receivables | £1.42 | £1.83 | |
Inventory | £3.06 | £2.29 | |
Other current assets | |||
Total current assets | £8.14 | £9.51 | |
Long term investments | |||
Property, plant & equipment | £4.77 | £5.15 | |
Goodwill | |||
Intangible assets | £0.926 | £0.872 | |
Other assets | |||
Deferred long term asset charges | |||
Total assets | £13.83 | £15.54 | |
Current liabilities | |||
Accounts payable | £0.559 | £0.326 | |
Short long term debt | |||
Other current liabilities | |||
Total current liabilities | £0.901 | £0.869 | |
Long term debt | |||
Other liabilities | |||
Deferred long term liabilities | |||
Minority interest | |||
Total liabilities | £0.927 | £1.34 | |
Stockholders' equity | |||
Stock option warrants | |||
Common stock | £0.102 | £0.102 | |
Retained earnings | £3.75 | £5.05 | |
Treasury stock | |||
Capital surplus | |||
Other stockholder equity | £0.058 | £0.058 | |
Total stockholder equity | £12.91 | £14.2 | |
Net tangible assets |
(in millions GBP) | 2022 | 2021 | ||
---|---|---|---|---|
Current assets | ||||
Cash | £6.13 | £17.78 | ||
Short term investments | £0.271 | £0.271 | ||
Net receivables | £2.75 | £2.05 | ||
Inventory | £2.18 | £1.44 | ||
Other current assets | ||||
Total current assets | £11.54 | £12.79 | ||
Long term investments | ||||
Property, plant & equipment | £5.11 | £5.37 | ||
Goodwill | £0.235 | £0.235 | ||
Intangible assets | £0.711 | £0.733 | ||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | £17.36 | £18.9 | ||
Current liabilities | ||||
Accounts payable | £0.966 | £0.97 | ||
Short long term debt | ||||
Other current liabilities | £0.092 | £0.163 | ||
Total current liabilities | £1.71 | £1.79 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | £2.18 | £2.13 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | £0.102 | £0.114 | ||
Retained earnings | £6.03 | £7.61 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | £0.058 | £0.046 | ||
Total stockholder equity | £15.19 | £16.76 | ||
Net tangible assets |
Income statement
(in millions GBP) | 31 Mar 2024 | 31 Mar 2023 | |
---|---|---|---|
Revenue | |||
Total revenue | £1.66 | £2.36 | |
Cost of revenue | £1.31 | £1.98 | |
Gross profit | £0.344 | £0.384 | |
Operating activities | |||
Research & development | |||
Selling, general & administrative | £0.858 | £0.872 | |
Non-recurring | |||
Other operating expenses | -£0.096 | -£0.116 | |
Total operating expenses | £2.17 | £2.85 | |
Operating income | -£0.513 | -£0.488 | |
Income from continuing operations | |||
Net other income | -£0.096 | -£0.116 | |
EBIT | |||
Interest expense | |||
Income before tax | -£0.308 | -£0.448 | |
Income tax expense | -£0.062 | -£0.067 | |
Minority interest | |||
Net income from continuing ops | |||
Non-recurring events | |||
Discontinued operations | |||
Extraordinary items | |||
Effect of accounting change | |||
Other items | -£0.206 | -£0.04 | |
Net income | |||
Net income | -£0.246 | -£0.382 | |
Income (for common shares) | -£0.246 | -£0.382 |
(in millions GBP) | 2022 | 2021 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | £12.34 | £11.68 | ||
Cost of revenue | £8.58 | £8.15 | ||
Gross profit | £3.76 | £3.54 | ||
Operating activities | ||||
Research & development | £0.583 | £0.736 | ||
Selling, general & administrative | £3.07 | £3.08 | ||
Non-recurring | ||||
Other operating expenses | -£1.13 | -£1.36 | ||
Total operating expenses | £11.64 | £11.23 | ||
Operating income | £0.695 | £0.453 | ||
Income from continuing operations | ||||
Net other income | -£1.13 | -£1.36 | ||
EBIT | ||||
Interest expense | ||||
Income before tax | £0.705 | £0.453 | ||
Income tax expense | £0.094 | £0.047 | ||
Minority interest | ||||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | -£0.01 | |||
Net income | ||||
Net income | £0.611 | £0.406 | ||
Income (for common shares) | £0.611 | £0.406 |
Cash flows
(in millions GBP) | 31 Mar 2023 | 31 Dec 2022 | |||
---|---|---|---|---|---|
Net income | -£0.382 | -£0.382 | |||
Operating activities | |||||
Depreciation | £0.116 | £0.116 | |||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -£0.16 | -£0.16 | |||
Investing activities | |||||
Capital expenditures | -£0.14 | -£0.14 | |||
Investments | |||||
Other cash flows from investing | -£0.096 | -£0.096 | |||
Total cash flows from investing | -£0.236 | -£0.236 | |||
Financing activities | |||||
Dividends paid | -£0.112 | -£0.112 | |||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | |||||
Total cash flows from financing | -£0.112 | -£0.112 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | -£0.509 | -£0.509 |
(in millions GBP) | 2022 | 2021 | ||
---|---|---|---|---|
Net income | £0.611 | £0.406 | ||
Operating activities | ||||
Depreciation | £0.543 | £0.629 | ||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -£0.091 | £2.1 | ||
Investing activities | ||||
Capital expenditures | -£0.28 | -£0.179 | ||
Investments | ||||
Other cash flows from investing | -£0.194 | -£0.092 | ||
Total cash flows from investing | -£0.474 | -£0.271 | ||
Financing activities | ||||
Dividends paid | -£0.17 | |||
Sale and purchase of stock | -£2.02 | -£6.71 | ||
Net borrowings | ||||
Other cash flows from financing | ||||
Total cash flows from financing | -£2.19 | -£6.71 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -£2.75 | -£4.88 |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Mar 2022 | 31 Dec 2021 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $907.2 | $1,185.2 | |||
Short term investments | $10.5 | $169 | |||
Net receivables | $233.4 | $242.5 | |||
Inventory | |||||
Total current assets | $1,266.7 | $1,648.6 | |||
Long term investments | |||||
Property, plant & equipment | $120.7 | $116.7 | |||
Goodwill & intangible assets | $4,421.6 | $4,501.6 | |||
Total noncurrent assets | $4,593.3 | $4,710.3 | |||
Total investments | $10.5 | $169 | |||
Total assets | $5,860 | $6,358.9 | |||
Current liabilities | |||||
Accounts payable | $48.4 | $95.6 | |||
Deferred revenue | $746.7 | $748.4 | |||
Short long term debt | $17.9 | $17.1 | |||
Total current liabilities | $1,127.6 | $1,563.4 | |||
Long term debt | $1,673.7 | $1,477.2 | |||
Total noncurrent liabilities | $1,826.3 | $1,683.6 | |||
Total debt | $1,691.6 | $1,494.3 | |||
Total liabilities | $2,953.9 | $3,247 | |||
Stockholders' equity | |||||
Retained earnings | -$2,354.2 | -$2,406 | |||
Other stockholder equity | -$138.3 | -$107.1 | |||
Total stockholder equity | $2,906.1 | $3,111.9 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $1,185.2 | $1,500.4 | ||
Short term investments | $169 | $208.4 | ||
Net receivables | $242.5 | $217.5 | ||
Inventory | ||||
Total current assets | $1,648.6 | $1,859.8 | ||
Long term investments | $2 | |||
Property, plant & equipment | $116.7 | $171.2 | ||
Goodwill & intangible assets | $4,501.6 | $3,998.9 | ||
Total noncurrent assets | $4,710.3 | $4,346.7 | ||
Total investments | $169 | $210.4 | ||
Total assets | $6,358.9 | $6,206.5 | ||
Current liabilities | ||||
Accounts payable | $95.6 | $57.2 | ||
Deferred revenue | $748.4 | $748 | ||
Short long term debt | $17.1 | $18.5 | ||
Total current liabilities | $1,563.4 | $1,325.4 | ||
Long term debt | $1,477.2 | $1,411.9 | ||
Total noncurrent liabilities | $1,683.6 | $1,939.6 | ||
Total debt | $1,494.3 | $1,430.4 | ||
Total liabilities | $3,247 | $3,265 | ||
Stockholders' equity | ||||
Retained earnings | -$2,406 | -$2,284.3 | ||
Other stockholder equity | -$107.1 | -$50.7 | ||
Total stockholder equity | $3,111.9 | $2,941.5 |
Income statement
(in millions USD) | 31 Mar 2022 | 31 Dec 2021 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $691.2 | $695.5 | |||
Cost of revenue | $252.2 | $260.1 | |||
Gross profit | $439 | $435.4 | |||
Operating activities | |||||
Research & development | $112.4 | $151.9 | |||
Selling, general & administrative | $311.6 | $284.7 | |||
Total operating expenses | $424 | $436.6 | |||
Operating income | $15 | -$1.2 | |||
Income from continuing operations | |||||
EBIT | $0.2 | -$10.2 | |||
Income tax expense | $21.6 | $42.1 | |||
Interest expense | $3.1 | $15 | |||
Net income | |||||
Net income | -$24.5 | -$67.3 | |||
Income (for common shares) | -$24.5 | -$67.3 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $2,800.5 | $1,974.8 | ||
Cost of revenue | $1,014.9 | $811.8 | ||
Gross profit | $1,785.6 | $1,163 | ||
Operating activities | ||||
Research & development | $545.9 | $713.7 | ||
Selling, general & administrative | $1,117.1 | $819.5 | ||
Total operating expenses | $1,729.8 | $1,533.2 | ||
Operating income | $55.8 | -$370.2 | ||
Income from continuing operations | ||||
EBIT | $51 | -$375.1 | ||
Income tax expense | $96 | $24 | ||
Interest expense | $59.2 | $30.3 | ||
Net income | ||||
Net income | -$104.2 | -$429.4 | ||
Income (for common shares) | -$104.2 | -$429.4 |
Cash flows
(in millions USD) | 31 Mar 2022 | 31 Dec 2021 | |||
---|---|---|---|---|---|
Net income | -$24.5 | -$67.3 | |||
Operating activities | |||||
Depreciation | $73.1 | $72.2 | |||
Business acquisitions & disposals | -$133.6 | -$286.1 | |||
Stock-based compensation | $45 | $42.2 | |||
Total cash flows from operations | -$202.7 | $157.9 | |||
Investing activities | |||||
Capital expenditures | -$10.3 | -$5.7 | |||
Investments | $156.6 | $82 | |||
Total cash flows from investing | -$7.7 | -$217.8 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | $7.3 | $18.3 | |||
Net borrowings | |||||
Total cash flows from financing | -$55 | $16 | |||
Effect of exchange rate | -$12.6 | -$19.3 | |||
Change in cash and equivalents | -$278 | -$63.2 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | -$104.2 | -$429.4 | ||
Operating activities | ||||
Depreciation | $255.8 | $158 | ||
Business acquisitions & disposals | -$512.6 | -$978.5 | ||
Stock-based compensation | $167.2 | $122.6 | ||
Total cash flows from operations | $253.8 | $429.2 | ||
Investing activities | ||||
Capital expenditures | -$12.5 | -$18.7 | ||
Investments | $38.1 | $911.3 | ||
Total cash flows from investing | -$500.9 | -$87.7 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $33.4 | $16.9 | ||
Net borrowings | -$1.2 | $856.7 | ||
Total cash flows from financing | -$41.4 | $689.8 | ||
Effect of exchange rate | -$26.7 | $15.8 | ||
Change in cash and equivalents | -$315.2 | $1,047.1 |
ZYXI
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $23.532 | $26.877 | |||
Short term investments | |||||
Net receivables | $28.35 | $27.824 | |||
Inventory | $14.366 | $14.572 | |||
Other current assets | |||||
Total current assets | $67.382 | $70.63 | |||
Long term investments | |||||
Property, plant & equipment | $16.282 | $17.325 | |||
Goodwill | $20.401 | $20.401 | |||
Intangible assets | $9.296 | $9.525 | |||
Other assets | $2.074 | $1.694 | |||
Deferred long term asset charges | $1.483 | $1.103 | |||
Total assets | $115.435 | $119.575 | |||
Current liabilities | |||||
Accounts payable | $5.139 | $5.236 | |||
Short long term debt | $5.333 | $5.333 | |||
Other current liabilities | $0.932 | $0.176 | |||
Total current liabilities | $19.77 | $18.823 | |||
Long term debt | $6.621 | $7.949 | |||
Other liabilities | $9.7 | $9.6 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $50.248 | $50.566 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.039 | $0.04 | |||
Retained earnings | $9.596 | $4.723 | |||
Treasury stock | -$26.321 | -$17.166 | |||
Capital surplus | $81.873 | $81.412 | |||
Other stockholder equity | |||||
Total stockholder equity | $65.187 | $69.009 | |||
Net tangible assets | $35.49 | $39.083 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $42.612 | $39.173 | ||
Short term investments | ||||
Net receivables | $28.632 | $13.837 | ||
Inventory | $10.756 | $8.635 | ||
Other current assets | ||||
Total current assets | $82.689 | $63.023 | ||
Long term investments | ||||
Property, plant & equipment | $18.913 | $8.239 | ||
Goodwill | $20.401 | |||
Intangible assets | $9.975 | |||
Other assets | $1.296 | $0.913 | ||
Deferred long term asset charges | $0.711 | $0.566 | ||
Total assets | $133.274 | $72.175 | ||
Current liabilities | ||||
Accounts payable | $4.739 | $4.709 | ||
Short long term debt | $5.333 | |||
Other current liabilities | $5.925 | $0.288 | ||
Total current liabilities | $22.871 | $10.117 | ||
Long term debt | $10.605 | |||
Other liabilities | $9.7 | |||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $59.349 | $15.32 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.041 | $0.036 | ||
Retained earnings | $23.43 | |||
Treasury stock | -$6.513 | -$3.846 | ||
Capital surplus | $80.397 | $37.235 | ||
Other stockholder equity | ||||
Total stockholder equity | $73.925 | $56.855 | ||
Net tangible assets | $43.549 | $56.855 |
Income statement
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $41.52 | $36.759 | |||
Cost of revenue | $8.391 | $7.205 | |||
Gross profit | $33.129 | $29.554 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $26.571 | $25.19 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $34.962 | $32.395 | |||
Operating income | $6.558 | $4.364 | |||
Income from continuing operations | |||||
Net other income | -$0.206 | -$0.215 | |||
EBIT | $6.558 | $4.364 | |||
Interest expense | -$0.106 | -$0.115 | |||
Income before tax | $6.352 | $4.149 | |||
Income tax expense | $1.479 | $0.803 | |||
Minority interest | |||||
Net income from continuing ops | $4.873 | $3.346 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | $4.873 | $3.346 | |||
Income (for common shares) | $4.873 | $3.346 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $130.301 | $80.122 | ||
Cost of revenue | $26.922 | $17.209 | ||
Gross profit | $103.379 | $62.913 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $81.013 | $52.664 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $107.935 | $69.873 | ||
Operating income | $22.366 | $10.249 | ||
Income from continuing operations | ||||
Net other income | -$0.095 | -$0.096 | ||
EBIT | $22.366 | $10.249 | ||
Interest expense | -$0.095 | -$0.019 | ||
Income before tax | $22.271 | $10.153 | ||
Income tax expense | $5.168 | $1.079 | ||
Minority interest | ||||
Net income from continuing ops | $17.103 | $9.074 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | $17.103 | $9.074 | ||
Income (for common shares) | $17.103 | $9.074 |
Cash flows
(in millions USD) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Net income | $4.873 | $3.346 | |||
Operating activities | |||||
Depreciation | $0.799 | $0.757 | |||
Net income adjustments | $0.855 | $0.603 | |||
Change in accounts receivable | -$0.526 | $0.021 | |||
Changes in liabilities | $1.384 | -$3.603 | |||
Changes in inventory | -$0.197 | -$1.537 | |||
Changes in other operating activities | $0.223 | $0.237 | |||
Total cash flows from operations | $7.411 | -$0.176 | |||
Investing activities | |||||
Capital expenditures | -$0.12 | -$0.14 | |||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | -$0.12 | -$0.14 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | -$1.362 | -$1.364 | |||
Other cash flows from financing | |||||
Total cash flows from financing | -$10.636 | -$12.054 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | -$3.345 | -$12.37 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | $17.103 | $9.074 | ||
Operating activities | ||||
Depreciation | $2.286 | $1.572 | ||
Net income adjustments | $2.775 | $2.391 | ||
Change in accounts receivable | -$14.781 | -$8.004 | ||
Changes in liabilities | $2.889 | $3.773 | ||
Changes in inventory | -$3.776 | -$7.323 | ||
Changes in other operating activities | $0.453 | -$0.665 | ||
Total cash flows from operations | $6.949 | $0.818 | ||
Investing activities | ||||
Capital expenditures | -$0.609 | -$0.985 | ||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | -$16.606 | -$0.985 | ||
Financing activities | ||||
Dividends paid | -$0.001 | -$0.001 | ||
Sale and purchase of stock | ||||
Net borrowings | $15.855 | -$0.057 | ||
Other cash flows from financing | -$0.016 | -$0.016 | ||
Total cash flows from financing | $13.096 | $25.3 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | $3.439 | $25.133 |